2021-11-16-世界卫生组织-Cervical_cancer_Tuvalu_2021_country_profile_1页_49kb

Summary of Tuvalu Cervical Cancer Profile

• Morbidity and Mortality: No available data for crude incidence, age-standardized incidence, cumulative risk, deaths, or mortality-to-incidence ratio from source reports released in 2020 or 2019. Mortality data for 2019 is not defined.

• Primary Prevention: HPV vaccination programme exists, with 22% coverage among girls by age 15, but full data unavailable for vaccination details. HPV is included in the national vaccination programme, but coverage data is not available. Tobacco use prevalence among women is 22% in 2020.

• Secondary Prevention Screening: No national screening programme exists; cytology is used in primary tests starting at age 30-49, with 28% of women aged 30-49 screened in the last 5 years. Referral systems are unclear.

• Treatment and Supportive Care: National guidelines exist, but few radiotherapy and brachytherapy units are available. Cancer diagnosis and treatment services are limited, with no cancer centers reported. Palliative care is available for non-communicable diseases.

• WHO Strategy for Elimination: Targets for 2030 are referenced, but specific data not provided. Note ND signifies data not available.